This inventor holds 1 USPTO granted patent. Top assignee: Molecular Genetics Research and Development Limited Partnership. Active years: 1987.
Company Filing History:
Years Active: 1987
Title: The Innovative Mind of William J DeLorbe
Introduction: William J DeLorbe is a notable inventor based in Minnetonka, MN, recognized for his contributions to the field of molecular genetics. His innovative approaches to RNA cloning have made significant impacts on research and development in genetic engineering.
Latest Patents: William J DeLorbe holds a patent for "Molecular cloning of RNA using RNA ligase and synthetic oligonucleotides." This patent details methods and compositions for inserting and cloning RNA within DNA cloning vectors. The patent describes a process where RNA molecules are modified by the ligation of oligonucleotide linkers onto the terminals of the RNA, utilizing T4 RNA ligase. These linkers, which can be composed of DNA, RNA, or mixtures of both, facilitate effective insertion and ligation of RNA species into DNA cloning vectors. The resultant recombinant vectors enable the transformation of host cells, promoting the generation of multiple DNA copies of the RNA molecule.
Career Highlights: DeLorbe's affiliation with Molecular Genetics Research and Development Limited Partnership showcases his blend of scientific knowledge and practical application in molecular biology. His work demonstrates an ongoing commitment to advancing genetic research and technology.
Collaborations: Throughout his career, William J DeLorbe has collaborated with esteemed colleagues, including Tomas Kempe and Anthony F. Purchio. These partnerships have enhanced the scope and application of his innovative work in molecular genetics.
Conclusion: William J DeLorbe stands out as a valuable contributor to the world of innovations in molecular genetics. His groundbreaking patent and collaborations reflect his dedication to pushing the boundaries of genetic research and technology. With a focus on the molecular cloning of RNA, DeLorbe's work continues to shape the future of genetic engineering.